List of Surgical Devices Companies in California - 63

Advanced Bifurcation Systems Inc. has developed a novel technology to enable effective stenting of coronary arteries at their branch points (bifurcations). This comprehensive platform is a paradigm shift in interventional cardiology that will reduce the need for open-heart surgery, hospitalizations, and repeat coronary angioplasties. The technology will simplify procedures and improve outcomes while reducing angioplasty times which results in significant improvement to the overall patient care at a reduced cost.

Alpha Medical Instruments,developer, manufacturer, Balloon flotation catheters, venous catherization, right heart, measurements, venous, pulmonary artery pressures, cardiac output

ATEC is a medical device company dedicated to revolutionizing the approach to spine surgery through innovation. ATEC’s Organic Innovation Machine™ is the greatest concentration of spine knowhow in the industry and committed to the creation of clinical distinction. Leveraging 100% spine focus and expertise, we seek to improve spine surgery by rethinking, redesigning and seamlessly integrating the technologies required from the ground up. The innovation that results from that process is being rapidly adopted because, like us, spine surgeons covet informatic and procedural sophistication that enables more predictable, more reproducible care. Our flagship technology, the Prone TransPsoas (PTPTM) Procedure, leveraged decades of experience to advance first-generation lateral surgery with a more familiar patient position and elevated neuromonitoring.   EOS imaging, the backbone of ATEC’s informatic ecosystem, provides radiographic imaging, enabling standing, full-body, global alignment assessments. We are further developing EOS technology to elevate spine care with unprecedented capabilities. Our vision is to be the standard bearer in spine. Visit our website for more information: www.atecspine.com

The mission of Alume Biosciences is to make our proprietary nerve illumination technology available for surgeons so that patients everywhere can benefit. Learn how you can help us move surgery into the light.

Established in 1993 in California, USA, Amsino is a leading medical device developer and manufacturer dedicated to advancing healthcare worldwide by developing, manufacturing, and marketing medical products that help improve the safety and effectiveness of patient care. The Amsino product portfolio includes Sterile Water and Saline, IV Therapy, Waste Fluid Management, Respiratory, Urology, and Enteral Feeding products. Amsino products are distributed in the United States and more than 80 countries worldwide. Visit www.amsino.com for our complete product offering.

Stem cell renewal, maintenance and tissue regeneration are critical for normal health and well-being. Wnt pathway interactions are crucial to maintenance of these processes. Ankasa is the first to produce human Wnt proteins in a manufacturing setting suitable for use in humans, leading to clinical candidate ART352-L. Successful development of ART352-L will enhance the osteogenic properties of patient derived stem cells used in reconstructive surgeries and provide safe and effective enhancement of bone formation in indications for which this is a significant unmet medical need.

Applied Surgical Robotics is a MedTech company focused on developing robotic technology and SaaS software solutions to improve surgical precision.

Avenu Medical is a well-established medical device company dedicated to creating a paradigm shift in vascular access for hemodialysis patients. Our focus is to pursue unmet clinical needs by developing a minimally invasive, cost effective and efficient approach to vascular access. Founded in 2010 and headquartered in Orange County, California, we have developed the Ellipsys® Vascular Access System, an innovative, image-guided, single catheter system used to percutaneously create an arteriovenous (AV) fistula for hemodialysis access. Over the past three years, the Ellipsys System has been used in clinical trials outside the United States. In December 2014, we received approval from the Food and Drug Administration (FDA) to begin a pivotal Phase III clinical trial in the United States through an Investigational Device Exemption (IDE). Patient enrollment for the trial was completed in June 2016. The Ellipsys System has received FDA approval and European CE Mark approval for the creation of an arteriovenous fistula in patients with chronic kidney disease requiring hemodialysis.

Avinger, Inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (PAD). PAD is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. The company’s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. Avinger’s current lumivascular products include the Lightbox imaging console, the Ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions, or CTOs, and Pantheris, the first-ever image- guided atherectomy device, designed to precisely remove arterial plaque in PAD patients.

Axcess Surgical is a medical devices company that specializes in creating advanced surgical innovations for optimum results.

Axon Therapies is addressing a root cause of heart failure with their frontline therapy by selectively ablating the neural pathway carrying information from the chronically hyperactive sympathetic nervous system (SNS) in order to restore volume balance, stop disease progression and improve symptoms

Caldera Medical is a medical device company solely focused on women's health with a commitment to our mission of "Improving the Quality of Life for Women!" We develop, build and market best in class surgical products for the treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse. Working closely with surgeons to help those here at home, as well as women around the world, through our humanitarian programs to give them the access to the education and treatment they deserve. Mission - To Improve the Quality of Life for Women Vision - To be the Global Leader in Women's Pelvic Health Values "C4"​ - Care / Collaborate / Challenge / Create

Cannuflow is a healthcare technology company that offers innovative fluid management solutions for knee, shoulder, and hip arthroscopy procedures.

At Capstan Medical, we’re driven by an unwavering commitment to transforming the treatment of structural heart disease. By merging surgical robotics with catheter-based technology and next generation implants, we’ve pioneered a patient-optimized approach to repair and replace heart valves.

ClearFlow, Inc. is a medical device company that specializes in innovative surgical drainage solutions. Founded in 2007 by cardiothoracic surgeons Dr. Edward Boyle and Dr. Marc Gillinov, the company focuses on improving outcomes in cardiac surgery by addressing complications related to retained blood and fluids after surgery. The company's primary offering is the PleuraFlow Active Tube Clearance System, a chest tube designed with Active Clearance Technology (ACT). This system helps maintain patency and prevent occlusions, reducing the risk of "failure to drain" events that can lead to longer hospital stays and increased costs. ClearFlow's products are targeted at hospitals and healthcare facilities performing cardiothoracic surgeries, particularly in intensive care units. Led by President and CEO Paul Molloy, ClearFlow is committed to developing devices that enhance patient recovery and reduce healthcare costs. The company has received FDA 510(k) clearance and the CE Mark for its PleuraFlow system, reflecting its dedication to providing reliable solutions for clinicians.

A surgical device company dedicated to cutting costs, prioritizing patients, and simplifying surgery.

CompactCath is a medical device company committed to improving the quality of life for self-catheterizing patients, their families, and healthcare providers. Designed and founded at Stanford University by a team of physicians, engineers, and catheter users, we are driven by a goal to design medical devices that enable those with chronic conditions to lead active, thriving, independent lives. CompactCath, our flagship intermittent urinary catheter, is a revolutionary pre-lubricated, non-touch catheter for users looking for a compact, discreet, and easy to use solution that fits seamlessly in their lives. CompactCath is FDA cleared in the US and CE approved in Europe. For more information, visit our website: www.compactcath.com and watch our video: https://www.youtube.com/watch?v=k8cjjgfGhAY

Cortex aims to transform the diagnosis and treatment of atrial arrhythmias by providing insight into each individual patient's disease pathophysiology. The OptiMap™ System is a 510k cleared, electrographic flow mapping solution designed with AI, enabling physicians to See What Matters.

The company works with doctors to develop medical devices related tostructural heart disease and critical care monitoring.

ENCOLL CORP. is a medical devices company based out of 4576 ENTERPRISE STREET, FREMONT, California, United States.

Field Medical, Inc. is a medical technology company based in Cardiff-by-the-Sea, California, focused on developing advanced pulsed field ablation (PFA) systems for treating cardiac arrhythmias. Founded in 2022 by Dr. Steven Mickelsen, a pioneer in PFA technology, the company is dedicated to improving catheter-based ablation therapies to meet clinical needs. Field Medical has made significant progress, moving from preclinical development to clinical trials, and has secured substantial funding to support its initiatives. The company's flagship product, the FieldForce Ablation System, includes the FieldForce Catheter and FieldForce Generator. The catheter is designed for ventricular arrhythmias, providing precise lesion formation with real-time force feedback. The generator utilizes proprietary FieldBending™ technology to deliver high-intensity pulsed electric fields, targeting arrhythmias while minimizing damage to surrounding tissue. Field Medical's clinical programs focus on ventricular tachycardia and atrial fibrillation, with promising early results from pilot studies and ongoing first-in-human trials. The company aims to establish PFA as the standard of care in cardiac ablation, leveraging its innovative technology and strategic funding to enhance its market presence.

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite for use as a standalone procedure in patients with refractory glaucoma; iStent SA, a two-stent product that is designed for use as a standalone glaucoma procedure; iDose Travoprost, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication; and MicroShunt, an ab-externo device for treatment of open-angle glaucoma. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was founded in 1998 and is headquartered in San Clemente, California.

The Future of Microsurgery is Robotics and AI. Horizon Surgical Systems, founded in 2021 by experts in ophthalmology and medical robotics, is at the forefront of innovation in microsurgery. Our groundbreaking product, Polaris, leverages state-of-the-art robotics, advanced medical imaging, and AI to extend the capabilities of surgeons beyond their current limitations. With a foundation rooted in academic excellence and a vision for the future, Horizon is committed to revolutionize global healthcare through technological innovation, bringing a new era of precision, enhanced outcomes, and safety to eye care.

Hospi is a healthcare technology company that innovates practical medical devices to enhance patient comfort and wellbeing, ease caregiver burden, and reduce cost.

ICU Medical connects patients and caregivers through safe, life-saving, life-enhancing IV therapy systems, software, solutions, and consumables. Since IV therapy is our only business, meeting your IV needs with quality products and consistent supply is our only concern. We are 100% focused on bringing you intuitive, patient-centric IV products and services that provide meaningful clinical differentiation, consistent innovation, and superior value. We design our products to work within your existing workflows to minimize disruption and maximize the time you spend with patients. Together, we help forge the human and emotional connections that enhance clinical experience and are the essence of outstanding quality of care. For more than three decades, we have been dedicated to a singular purpose—improving the safety and efficiency of IV therapy. With the acquisition of Hospira Infusion Systems from Pfizer in 2017, we became the only company to focus exclusively on IV therapy across the continuum of care. Our focus allows us to bring you: > Dedicated and non-dedicated IV sets and needlefree connectors clinically proven to provide an effective barrier against bacterial transfer and colonization. > The industry's broadest IV smart pump offering covering large volume, pain management, and ambulatory needs. > IV medication safety software providing full IV-EHR interoperability with the highest customer satisfaction and compatibility with more EHR systems than any other company. > Significant US IV solutions manufacturing and supply capabilities.

Imperative Care is a Silicon Valley-based medical technology company researching and developing connected innovations to elevate care for people affected by devastating vascular diseases such as stroke and pulmonary embolism. The company has four businesses focused on addressing specific gaps in treatment and care to make an impact across the entire patient journey. Follow Imperative Care Stroke, Imperative Care Vascular, Telos Health and Kandu Health for product and business-level updates.

InterVene is a medical device start-up company reinventing the way physicians treat severe venous disease in the legs. InterVene's BlueLeaf(TM) Endovenous Valve Formation System represents the first ever non-implantable, endovenous approach to deep vein valve failure. This technology allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. Millions of Americans currently suffer from painful venous stasis ulcers (VSU’s) and other costly and devastating symptoms, yet no minimally invasive therapy exists to treat deep vein valve failure, one of the most prevalent underlying causes of these symptoms. InterVene plans to change that. InterVene was originally a product of the Stanford Biodesign Fellowship and is a former Company In Residence at the Fogarty Institute for Innovation. InterVene's offices are now located in South San Francisco near SFO airport.

Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, Calif., is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. At Intuitive, we believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints.

IRIDEX is a worldwide leader in developing and manufacturing innovative and versatile light-based medical systems and delivery devices to treat glaucoma and retinal diseases. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. We are dedicated to a standard of excellence, offering superior technology for superior results. Our products are sold in the United States and Germany through a direct sales force and in over 100 countries through a network of approximately 70 independent distributors. Some of our products include the Cyclo G6 glaucoma laser, IQ 577 retinal laser, IQ 532 retinal laser, and TxCell scanning laser delivery device. Learn more at iridex.com

Corneal Surgery Devices

Meditrina is an innovative start up Company located in San Jose, CA, and founded in 2016 developed the Aveta™ hysteroscopy suite which was designed to provide physicians with the best care in their diagnosis and treatment of endometrial polyps and uterine fibroids. The system seamlessly integrates into any operating, procedure, or exam room. This new hysteroscopy system is an all-in-one platform which includes the single-use Aveta™ Pearl Hysteroscope for myomectomy, and the single-use Aveta™ Coral Hysteroscope for polypectomy procedures with integrated tissue resection and fluid management capability. The Aveta™ Pearl Hysteroscope is the first single-use hysteroscope to include full physician control providing proprietary fluid management and video control function directly on the hysteroscope handle.

MedSpark is a medical technology company that specializes in developing innovative medical devices.

MicroSkin® is used in ALL Cymed pouching systems. It is a transparent, hypoallergenic polyurethane film. MicroSkin® offers a level of comfort and security unmatched by any other product on the market Designed with an emphasis on comfort and durability, at just 1/1000 of an inch thick and the ability to stretch up to 500%, the MicroSkin barrier accomplishes a comfort unparalleled with any other pouching system on the market.

Mizuho OSI is the leader in the markets for specialty surgery and patient positioning. The company’s portfolio includes specialty surgical tables for procedure-specific approaches that improve patient outcomes in spine and orthopedic surgeries along with disposable and reusable surgical patient care products.

Reimagining. Redesigning. What are the possibilities when it comes to sustainability for the future and innovation for today? That's what we ask ourselves at NewGen Surgical. Founded in 2012 in the San Francisco Bay Area, and recipient of the California Product Stewardship Green Arrow Award for circular economy innovation, NewGen Surgical develops healthcare products that minimize environmental impact without clinical compromise, protecting the foundation of all health - our environment. NewGen Surgical offers the world's first upcycled, plant-based medical devices for the O.R. that minimize plastic, fossil fuel dependency, CO2e and chemicals of concern. Over 1,000,000 products have been delivered to date, equating to 42 tons of plastic and 48 metric tons of carbon eliminated from the healthcare supply chain.

Noah Medical is a medical technology company based in San Carlos, California, founded in 2018. The company specializes in developing advanced medical robotics aimed at enhancing diagnostic procedures in pulmonology. Its flagship product, the Galaxy System, is a robotic platform that integrates real-time navigation, augmented fluoroscopy, and tomosynthesis to improve the accuracy of lesion localization, which is vital for early lung cancer diagnosis and treatment. With a team of over 150 engineers and industry experts, Noah Medical leverages extensive experience from leading healthcare companies. The company's mission focuses on saving lives through early diagnosis and treatment, particularly in robotic navigated bronchoscopy. Noah Medical has received recognition as a "Fierce 15" company of 2023 and has raised $150 million in funding to support its innovative approach. Its technology is designed to enhance procedural efficiency and diagnostic accuracy in healthcare facilities, particularly in pulmonology and oncology.

Ocutrx Technologies, Inc. is a high-tech company that specializes in augmented reality (AR), extended reality (XR), and 3D visualization technologies. They develop innovative solutions for various sectors, including medical, military, consumer, and enterprise applications. Ocutrx aims to enhance how users interact with visual data, focusing on improving situational awareness and accessibility for visually impaired individuals. The company offers several products, including the OcuLenz AR/XR headset, which assists patients with advanced macular degeneration and is also suitable for gaming and telemedicine. Their ORLenz system enhances surgical visualization, allowing surgeons to interact more effectively with patient data. Ocutrx also provides customizable AR/XR platforms for developers and enterprises, promoting productivity and immersive experiences. Ocutrx serves a diverse range of customers, including healthcare professionals, military personnel, and developers creating AR/XR applications. The company holds over 25 patents related to AR/XR innovations, particularly in healthcare, showcasing their commitment to advancing technology in this field.

OD-OS aims to set new standards of care for retina treatment. By extending our innovative Retina Navigation platform, our goal is to become the global leader in novel therapeutic solutions for the growing number of people suffering from retina diseases. Join the Navilas mailing list: https://tinyurl.com/od-os-mailing-list Follow us on Twitter: https://twitter.com/OD_OS_Navilas Privacy Policy Social Media Pages: https://www.od-os.com/legal-notice-container/privacy-policy/social-media

Okami Medical, Inc. is a medical device company focused on developing innovative solutions that address key unmet clinical needs in peripheral vascular intervention.

Polares medical is a medical device company with a novel device for treating mitral valve regurgitation.

PROCEPT BioRobotics is a medical robotics company that specializes in minimally invasive robotic surgery technology.

In the simplest sense, we're a company that creates solutions. More specifically, we design novel access device technology for neurovascular interventions and unmet clinical needs. Because in the precious seconds that surround a stroke emergency, clinicians need technology that delivers. That's where we come in.

Founded in 2006 with offices in Minneapolis, MN and Sunnyvale, CA, Relievant Medsystems is a privately held medical device company developing new solutions to improve the quality of life for millions of patients suffering from chronic vertebrogenic low back pain. Relievant’s Intracept® System delivers targeted energy into the spine and blocks the transmission of pain signals from the basivertebral nerve. This minimally invasive procedure provides spine surgeons and interventional spine physicians with a new way to provide clinically proven, durable pain relief for chronic vertebrogenic low back pain.

RenovoRx is a clinical-stage biopharmaceutical company focused on fighting cancer through the localized treatment of difficult to treat tumors via our proprietary RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP®) therapy platform. RenovoTAMP utilizes approved chemotherapeutics with validated mechanisms of action and well-established safety and side effect profiles, with the goal of increasing their efficacy, improving their safety, and widening their therapeutic window. Our lead product candidate, RenovoGem, is a combination of gemcitabine and our patented delivery system regulated by the FDA as a novel oncology drug product to treat unresectable locally advanced pancreatic cancer (LAPC). Targeted therapy via RenovoTAMP platform safely and without transmission to non-targeted areas, is our primary focus. RenovoRx’s patent portfolio currently includes seven issued US patents and one European patent for ourtechnology with several additional patents pending in the US, Europe, and Asia. After demonstrating a median survival of 27.9 months in Phase 1/2 clinical trials vs. 12-15 months reported in historical studies for this patient population, RenovoRx secured two separate Orphan Drug Designations from the FDA for intra-arterial gemcitabine: pancreatic cancer and bile duct cancer (cholangiocarcinoma). This therapy is being further studied in the currently enrolling Phase 3 TIGeR-PaC clinical trial in pancreatic cancer and has a primary endpoint of overall survival and several secondary endpoints, including quality of life. The Phase 3 TIGeR-PaC clinical trial is enrolling unresectable locally advanced pancreatic cancer patients (LAPC) in the United States.

REVA Medical, LLC. is a leader in bioresorbable polymer technologies for vascular applications. REVA's lead product, Fantom Encore, is a drug-eluting bioresorbable scaffold for the treatment of coronary artery disease. Fantom Encore is made from Tyrocore, REVA’s proprietary tyrosine derived polymer. Unlike metallic stents, Fantom Encore is designed support the artery through the healing process, and then disappear (or “resorb”) from the body in order to restore natural function to the artery. Learn more at www.revamedical.com.

Sanovas, Inc. is a life science asset holding company that is developing and accelerating companies that create medical technologies which are advancing the next generation of minimally invasive surgical tools and technologies.

Siemens Healthineersenables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare.COVID-19: CE mark for its molecular Fast Track Diagnostics (FTD)SARS-CoV-2 Assay.

We are reimagining eyecare with transformative technology and an interventional mindset. We believe interventions should happen sooner to preserve, protect, or restore natural eye function. So, we aim to provide eyecare providers with transformative, clinically-proven therapies that are intuitive, less invasive, and more intelligent.

Silk Road Medical, Inc. is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on the company, visit our website at http://silkroadmed.com/. The TransCarotid Artery Revascularization (TCAR) Procedure is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The ENROUTE® Transcarotid Neuroprotection and Stent System are the first and only products specifically designed and indicated for TCAR in high surgical risk patients that need carotid intervention. For more information about the TCAR procedure and essential prescribing information, please visit http://silkroadmed.com/ifus/. For more information about carotid artery disease and the risks involved with any intervention (e.g. bleeding, death, myocardial infarction, restenosis, stroke, TIA, vessel dissection, vessel occlusion, etc.), please visit http://silkroadmed.com/disease-and-treatment-options/.

SinuSys Corporation is a medical device company focused on developing new therapies to improve the sinus health of patients. The company’s first product, the Vent-Os™ Sinus Dilation System, is designed to resolve sinusitis symptoms in a simple, two-step interventional procedure. The device enables gradual dilation of the sinus ostia, which is intended to maximize patient tolerability of the procedure in an office setting under local anesthesia. Unlike balloon dilation devices that use rapid, high-pressure inflation, the Vent-Os Sinus Dilation System is a small, low-pressure, self-expanding insert designed to gently and gradually open the maxillary ostia. The Vent-Os System incorporates the Company’s proprietary osmotic technology, which utilizes the body’s natural mucosal fluids to expand the insert before removal. In an office setting, patients are comfortably relocated to the waiting room between insertion and removal of the device.

Solinas Medical is a medical device company that specializes in modernizing vascular access technology for hemodialysis, with a focus on reducing cannulation-related complications and healthcare costs.

STAAR Surgical Company (an S&P 400 midcap company trading under NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye has been dedicated solely to ophthalmic surgery for over 35 years. The company offers the EVO Visian implantable Collamer® lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery is called an Implantable Collamer Lens or "ICL"​. Over 1,00,000 Visian ICLs have been implanted to date. It also provides minimally invasive intraocular lenses (IOLs), including foldable IOLs for use in minimally invasive cataract surgical procedures; aspheric IOLs that produce a clearer image than traditional spherical lenses; nanoFLEX IOL, a single piece Collamer aspheric optic; and Toric IOLs for cataract patients, as well as preloaded injectors for use in cataract surgery. In addition, the company sells surgical products, and other related instruments and devices, as well as injector parts; and manufactures AquaFlow devices for the treatment of glaucoma. It markets its products to health care providers, including surgical centers, hospitals, managed care providers, health organizations, group purchasing organizations, and government facilities primarily under the STAAR, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, Epiphany, and AquaFlow trademarks. The company sells products directly through its sales representatives and independent distributors in more than 75 countries. STAAR Surgical Company was founded in 1982 and is headquartered in Lake Forest, California. Its manufacturing plant is located in Monrovia, CA.

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at stryker.com and careers.stryker.com. Facts: ● 2023 Sales: $20.5 billion ● Industry: Medical Instruments & Supplies ● Employees: 52,000 worldwide ● 40 years of sales growth leading up to 2020 ● 44+ Manufacturing and R&D Locations Worldwide ● $1.4 billion spent on research and development in 2023 ● ~12,900 patents owned globally in 2023 ● Products sold in ~75 countries ● Fortune 500 Company ● 7 consecutive years as one of Fortune's World's Best Workplaces Stryker’s social media community guidelines: https://www.stryker.com/content/m/legal/social-media-community-guidelines/en/index.html Notice Regarding Employee Conduct on Facebook/LinkedIn Meta/LinkedIn does not permit employers to verify or validate “employees” in the (META: “Works at” LinkedIn: “Experience”) section of users’ profiles. Please be aware that the views expressed by individuals on their personal accounts and do not necessarily represent the views of our company. If you encounter any issues with a person claiming to be our employee, we recommend using the “Report Profile” feature. If you’d like to report concerns to our Ethics Hotline, you may do so at: https://app.convercent.com/en-us/LandingPage/b6bb4e84-9fcb-ea11-a974-000d3ab9f296

Supira Medical, Inc. is a portfolio company of Shifamed, LLC., a highly-specialized medical innovation hub focused on developing advanced solutions that get to market faster, reduce risk, increase impact, and forge a path toward a world where all people are able to lead longer, healthier lives.

Suture Ease is a medical device company that focuses on innovative development and commercialization of devices for laparoscopic surgery.

Repair Mesh

Since 2011, Tenex Health has pioneered minimally invasive relief for chronic tendon pain with a one-time ultrasonic treatment. Since 2012, more than 100,000 procedures using the Tenex Health TX technology have been performed. The device is designed for the removal of diseased soft and hard tissue and restoration of healthy musculoskeletal function. Our mission is to provide patients who suffer from chronic tendon pain with a minimally invasive solution to remove the cause of their suffering and get them back to the things they love and need to do with less downtime than traditional treatment methods or surgery. Using conventional ultrasound guidance and the breakthrough Tenex Health TX System, surgeons can quickly and precisely treat only the damaged tendon tissue, leaving the surrounding healthy tendon unharmed. Because the procedure uses ultrasonic energy applied with the TX MicroTip and typically no stitches or general anesthesia are required, there is minimal downtime. Individual results may vary. For more information, visit www.TenexHealth.com.

Delivering the latest innovation in sacroiliac joint surgical solutions, Tenon Medical is uniquely positioned to introduce a refined surgical option for patients with chronic sacroiliac joint pain that fail conservative care. The Catamaran™ SIJ Fusion System offers a patented new surgical solution that places a single implant directly into the SI joint. Tenon Medical is led by a powerful team with years of cumulative experience in designing and launching innovative surgical solutions that deliver a pathway to improved quality of life for thousands of patients.

Toro Neurovascular develops proprietary catheter technologies that enable physicians treating stroke to achieve the best possible patient outcomes.

TTI Medical specializes in video and digital camera adaptation onto surgical microscopes, ophthalmic slit lamps, and endoscopes. In addition, we are a distributor of Ikegami and Sony medical video cameras. We also manufacture various CO₂ laser accessories, fiberoptic handpieces, and re-usable suction/irrigation instruments. TTI Medical was established in 1984 with the mission of designing and marketing high quality, technologically advanced surgical instruments and medical devices. Our product design criteria must pass critical tests for performance, convenience, dependability, and cost containment. Product quality is held to the highest standards. Opportunities within the medical marketplace are constantly being identified and evaluated for new product development. Patents protect the proprietary technology utilized in the ACCU-Beam® and ACCU-Surg® product lines. The fundamental principal of “universality” is incorporated in each product design. Universality ensures the end user of maximum utilization at the lowest possible cost. Our philosophy of producing high quality reusable surgical devices focuses on the cost containment criteria required within the hospital managed care environment. Our quality policy is to provide products that satisfy the requirements of our customers including regulatory, design, and cost specifications. Products shall be produced under a management system in compliance with quality standards of ISO 13485:2016, FDA 21CFR820, and the European Medical Device Regulation 2017/745. Our policy is to be in compliance with all regulations that apply to the products in countries where our products are distributed. Products shall only be released if they conform to specifications without functional defect.

United Biologics, Inc. is a California-based medical device manufacturer with over 22 years of experience. The company specializes in creating anatomically precise silicone vascular models for medical simulation, training, and device development. Located in Irvine, California, United Biologics serves leading medical device companies worldwide, particularly in the intravascular therapy market. The company produces silicone replicas of human vasculature, which are used for medical training, device research and development, and marketing purposes. These models provide realistic training environments for physicians and serve as cost-effective alternatives to animal testing. United Biologics is recognized for its exclusive focus on silicone vascular replication and is trusted by top-tier medical device innovators.

UroViu Corporation's mission is to revolutionize the cystoscopy platform for improved patient care and efficiency and has operations in California and Washington and production facilities in Asia. UroViu is the developer of the always ready cystoscopy platform, the most portable, self-contained and versatile single-use cystoscopy solution on the market. The intuitive portable platform and product suite are protected by a portfolio of 13 granted and many more pending patents. UroViu's vision is to simplify the scope of patient care.

Xpan is Developing the Next Generation of Minimally Invasive Surgical Access Ports